Serotyping of Cryptococcus neoformans strains isolated from clinical specimens in Thailand and their susceptibility to various antifungal agents

European Journal of Epidemiology

Volumn 13, Issue 3, 1997, Pages 335-340

  Poonwan, Natteewan ^a   Mikami, Yuzuru ^b   Poosuwan, Suwan ^a   Boon Long, Jotica ^a   Mekha, Nanthawan ^a   Kusum, Mayura ^a   Yazawa, Katsukiyo ^b   Tanaka, Reiko ^b   Nishimura, Kazuko ^b   Konyama, Kazuichi ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

AIDS patients; Antifungal agents; Clinical isolates; Cryptococcus neoformans; RAPD analysis; Serotyping; Susceptibility

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; MICONAZOLE;

ANTIBIOTIC SENSITIVITY; ARTICLE; CRYPTOCOCCUS NEOFORMANS; DNA DETERMINATION; GEOGRAPHIC DISTRIBUTION; SEROTYPE; THAILAND;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIFUNGAL AGENTS; CEREBROSPINAL FLUID; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; HUMANS; MICROBIAL SENSITIVITY TESTS; SEROTYPING; THAILAND;

EID: 8544239347     PISSN: 03932990     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007376917836     Document Type: Article

References (27)

1. Ellis DH, Pfieffer TJ. Ecology, life cycle, and infectious propagule of Cryptococcus neoformans. The Lancet 1990; 336: 923-925.
2. Ellis DH, Pfeiffer TJ. Cryptococcosis and the ecology of Cryptococcus neoformans. Jpn J Med Mycol 1994; 35: 111-122.
3. Kwon-Chung KJ, Wickes BL, Stockman L, Roberts GD, Ellis DH, Howard DH. Virulence, serotype, and molecular characteristics of environmental strains of Cryptococcus neoformans var. gattii. Infect Immun 1992; 60: 1869-1874.
4. Brandt ME, Hutwagner LC, Kuykendall RJ, Pinner RW (The Cryptococcal Disease Active Surveillance group). Comparison of multilocus enzyme electrophoresis and random amplified polymorphic DNA analysis for molecular subtyping of Cryptococcus neoformans. J Clin Microbiol 1995; 33: 1890-1895.
5. Polacheck I, Lebens G, Hicks JB. Development of DNA probes for early diagnosis and epidemiological study of cryptococcosis in AIDS patients. J Clin Microbiol 1992; 30: 925-930.
6. Powderly WG, Finkelstein DM, Feinberg J, et al. A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. New Eng J Med 1995; 332: 700-705.
7. Currie BP, Casadevall A. Estimation of the prevalence of cryptococcal infection among patients infected with the human immunodeficiency virus in New York City. Clin Infect Dis 1994; 19: 1029-1033.
8. Data from AIDS Newsletter, Division of AIDS, Department of CDC, Thailand, Vol. 8, August 1995.
9. Rippon JW. Medical mycology: The pathogenic fungi and the pathogenic actinomycetes. Philadelphia: WB Saunders 1982.
10. Kwon-Chung KJ, Bennett JE. High prevalence of Cryptococcus neoformans var. gattii in tropical and subtropical regions. Zbl Bakt Hyg 1984; A257: 213-218.
11. Goodwin PH, Annis SL. Rapid identification of genetic variation and pathotype of Leptosphaeria maculans by random amplified polymorphic DNA assay. Appl Environ Microbiol 1991; 57: 2482-2486.
12. Williams JK, Kubelik AR, Livak KJ, Rafalski JA, Tingey SV. DNA polymorphisms amplified by arbitary primers are useful as genetic markers. Nucleic Acids Res 1990; 18: 6531-6535.
13. Varma A, Swinne D, Staib F, Bennett JE, Kwon-Chung KJ. Diversity of DNA fingerprints in Cryptococcus neoformans. J Clin Microbiol 1995; 33: 1807-1814.
14. Pfaller MA, Dupont B, Kobayashi G, Muller J, Rinaldi MG, Espinel-Ingroff A, Shadomy S, Troke RF, Walsh J, Warnock DW. Standardized susceptibility testing of fluconazole: An international collaborative study. Antimicrob Agents Chemother 1992; 36: 1805-1809.
15. National Committee for Clinical Laboratory Standards (NCCLS). Reference method for broth dilution antifungal susceptibility testing of yeasts. Proposed standard M27-P. Villanova, PA: NCCLS.
16. Mikami Y, Sakamoto T, Yazawa K, Gonoi T, Ueno Y, Hasegawa S. Comparison of in vitro antifungal activity of itraconazole and hydroxy-itraconazole by colorimetric MTT assay. Mycoses 1994; 37: 27-33.
17. Mikami Y, Scalarone GM, Kurita N, Yazawa K, Ueno Y, Miyaji M. Synergistic postantifungal effect of flucytosine and fluconazole on Candida albicans. J Med Vet Mycol 1992; 30: 898-901.
18. 50 values and their combination effects. Chemotherapy 1991; 39: 1-8 (in Japanese).
19. Ansheng L, Nishimura K, Taguchi H, Tanaka R, Shaoxi W, Miyaji M. The isolation of Cryptococcus neoformans from pigeon droppings and serotyping of naturally and clinically sourced isolates in China. Mycopathologia 1993; 124: 1-5.
20. Kwon-Chung KJ, Bennett JE. Epidemiologic differences between the two varieties of Cryptococcus neformans. Am J Epidemiol 1984; 120: 123-130.
21. Cutsem J Van, Kurata H, Matsuoka H, Mikami Y, Pfaller MA, Scalarone GM, Rinaldi MG. Antifungal drug susceptibility testing. J Med Vet Mycol 1994; 32 (suppl 1): 267-276.
22. Kabasawa K, Itagaki H, Ikeda R, Shinoda T, Kagaya K, Fukazawa Y. Evaluation of a new method for the identification of Cryptococcus neoformans which uses serologic tests aided by selected biological tests. J Clin Microbiol 1991; 29: 2873-2876.
23. Zhu H, Qu F, Zhu L-H. Isolation of genomic DNAs from plants, fungi and bacteria using benzyl chloride. Nucleic Acids Res 1993; 21: 5279-5280.
24. Kwon-Chung KJ, Varma A, Howard DH. Ecology of Cryptococcus neoformans and prevalence of its two varieties in AIDS and non-AIDS associated cryptococcosis. In: Vanden Bossche H, Mackenzie DWR, Gauwenbergh G, Van Cutsem J, Drouhet E, Dupont B (eds), Mycoses of AIDS patients. New York: Plenum Press, 1990: 103-113.
25. Varma A, Swinne D, Staib F, Bennett JE, Kwon-Chung KJ. Diversity of DNA fingerprints in Cryptococcus neformans. J Clin Microbiol 1995; 33: 1807-1814.
26. Casadevall A, Spitzer ED, Webb D, Rinaldi MG. Suspectibility of serial Crytococcus neoformans isolates from patients with recurrent cryptococcal meningitis to amphotericin B and fluconazole. Antimicrob Agents Chemother 1993; 37: 1383-1386.
27. Rex JH, Rinaldi MG, Pfaller MA. Resistance of Candida species to fluconazole. Antimicrob Agents Chemother 1995; 39: 1-8.